Tomoe Shimazaki

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Long-read direct RNA sequencing reveals epigenetic regulation of chimeric gene-transposon transcripts in Arabidopsis thaliana.

Long-read direct RNA sequencing reveals epigenetic regulation of chimeric gene-transposon transcripts in Arabidopsis thaliana.

Journal: Nature communications

Published: September 20, 2022

Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients.

Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: November 18, 2021

The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease.

The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: September 21, 2021

Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma.

Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: February 02, 2020

Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling.

Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling.

Journal: Carcinogenesis

Published: December 05, 2019

High serum angiopoietin-2 level predicts non-regression of liver stiffness measurement-based liver fibrosis stage after direct-acting antiviral therapy for hepatitis C.

High serum angiopoietin-2 level predicts non-regression of liver stiffness measurement-based liver fibrosis stage after direct-acting antiviral therapy for hepatitis C.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: October 19, 2019

Analysis of the optimal psoas muscle mass index cut-off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people.

Analysis of the optimal psoas muscle mass index cut-off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: October 18, 2019

Entecavir treatment of hepatitis B virus-infected patients with severe renal impairment and those on hemodialysis.

Entecavir treatment of hepatitis B virus-infected patients with severe renal impairment and those on hemodialysis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 16, 2019

Effects of resistance-associated variants in genotype 2 hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs.

Effects of resistance-associated variants in genotype 2 hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 06, 2019

Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter.

Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 28, 2019

Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting.

Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: December 28, 2018

The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment.

The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment.

Journal: Internal medicine (Tokyo, Japan)

Published: December 21, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026